禾伸堂生技股份有限公司參加 Atlanta 2019 AACR Annual Meeting (2019/3/29-4/3) poster presentation. 由 Dr. Eskouhie Tchaparian 於會議期間介紹本公司抗大腸/直腸癌新藥 CA102N
Subject: Nonclinical safety evaluation of CA102N, a hyaluronic acid (HA) and nimesulide (Nim) conjugate, for colorectal cancer treatment
The American Association for Cancer Research (AACR) was founded in 1907 "to further the investigation and spread the knowledge of cancer." Today, the AACR accelerates progress toward the prevention and cure of cancer by promoting research, education, communication, and collaboration.
AACR Annual Meeting 2019相關訊息可參考: